What is the approach to diagnosing and managing anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Approach to Anemia

Begin with a complete blood count (CBC) with red cell indices, reticulocyte count, and peripheral blood smear—these three tests form the foundation for classifying anemia and directing subsequent workup. 1, 2, 3

Initial Classification by MCV

The mean corpuscular volume (MCV) provides the primary framework for differential diagnosis 1, 2:

Microcytic Anemia (MCV < 80 fL)

Order iron studies immediately: serum ferritin, transferrin saturation (TSAT), and total iron-binding capacity (TIBC). 1, 2

  • Iron deficiency anemia is diagnosed when serum ferritin is < 30 μg/L (or < 15 μg/L without inflammation). 1, 2
  • If ferritin is elevated (> 100 μg/L) with low TSAT (< 20%), consider anemia of chronic disease/inflammation and measure C-reactive protein (CRP). 4, 1
  • When ferritin is elevated AND TSAT is elevated or when TSAT is low with ferritin 20-100 μg/L, suspect genetic disorders of iron metabolism or heme synthesis (sideroblastic anemia, IRIDA, hemochromatosis). 4
  • Hemoglobin electrophoresis should be ordered if iron studies are normal to evaluate for thalassemia. 4, 1

Common pitfall: Do not assume normal ferritin excludes iron deficiency—ferritin 20-100 μg/L can represent iron deficiency in the presence of inflammation. 2

Normocytic Anemia (MCV 80-100 fL)

The reticulocyte count distinguishes between production defects and hemolysis/blood loss. 1, 3, 5

  • Elevated reticulocyte count (> 2%): Indicates hemolysis or acute blood loss. Order peripheral smear for red cell morphology, direct antiglobulin test (Coombs), haptoglobin, LDH, and indirect bilirubin. 3, 5
  • Low/normal reticulocyte count (< 2%): Suggests impaired production. Evaluate for:
    • Anemia of chronic disease: Check CRP, ferritin (typically > 100 μg/L with low TSAT < 20%). 1, 2
    • Chronic kidney disease: Measure creatinine and estimated GFR. 1, 2
    • Early iron deficiency: Ferritin < 30 μg/L. 1, 2
    • Bone marrow pathology if other causes excluded. 3, 5

Macrocytic Anemia (MCV > 100 fL)

Order vitamin B12 and folate levels immediately. 1, 2

  • B12 deficiency is confirmed with low serum B12; consider methylmalonic acid and homocysteine if B12 is borderline. 2, 3
  • Folate deficiency is diagnosed with low serum or red cell folate. 2, 3
  • If vitamin levels are normal, evaluate for:
    • Medication effects (methotrexate, hydroxyurea, antiretrovirals). 1
    • Alcohol use. 4, 1
    • Myelodysplastic syndrome (especially if age > 60 or cytopenias in other cell lines). 4, 1

Essential Laboratory Tests for All Patients

Beyond the CBC with indices, obtain 1, 2:

  • Reticulocyte count: Distinguishes production defects from hemolysis/blood loss. 1, 3
  • Peripheral blood smear: Provides morphologic clues (target cells, spherocytes, schistocytes, ringed sideroblasts). 2, 3
  • Iron studies: Ferritin, TSAT, TIBC—essential even in normocytic anemia. 1, 2
  • Inflammatory markers: CRP helps identify anemia of chronic disease. 4, 1

Special Population Considerations

Chronic Kidney Disease (CKD)

  • Monitor hemoglobin every 3 months when GFR < 30 mL/min. 1
  • Complete workup is required if hemoglobin < 12 g/dL in women or < 13 g/dL in men. 1
  • Correct iron deficiency (ferritin < 100 μg/L or TSAT < 20%) before considering erythropoietin therapy. 1, 6
  • Do NOT target hemoglobin > 11 g/dL with erythropoiesis-stimulating agents—this increases risk of death, stroke, and cardiovascular events. 6

Inflammatory Bowel Disease (IBD)

  • Anemia is typically multifactorial: iron deficiency from blood loss plus anemia of chronic disease. 4
  • Minimum screening includes CBC, CRP, and serum ferritin at regular intervals based on disease activity. 4
  • Check vitamin B12 and folate annually in patients with extensive small bowel disease or resection. 4

Elderly Patients

  • Never attribute anemia to "normal aging"—always investigate the cause. 1
  • Screen for combined nutritional deficiencies (iron AND B12 deficiency can coexist). 1

When to Refer

Urgent hematology referral is indicated for: 2

  • Abnormalities in two or more cell lines (bicytopenia or pancytopenia)
  • Severe anemia (hemoglobin < 8 g/dL) without obvious cause
  • Suspected hemolysis
  • Unexplained anemia after complete workup

Gastroenterology referral for: 2

  • Iron deficiency anemia with hemoglobin < 11 g/dL in men or < 10 g/dL in non-menstruating women
  • Any iron deficiency anemia in adults without significant non-GI blood loss
  • Suspected colorectal malignancy

Genetic Microcytic Anemias: Red Flags

Consider genetic disorders when 4:

  • Microcytic anemia is refractory to iron supplementation
  • Family history of anemia
  • Ferritin > 100 μg/L with elevated TSAT (suggests iron loading disorders)
  • Low TSAT with ferritin 20-100 μg/L (suggests IRIDA)
  • Neurologic symptoms (suggests mitochondrial disorders)
  • Photosensitivity (suggests erythropoietic protoporphyria)

For X-linked sideroblastic anemia (XLSA), screen male probands' mothers, sisters, and daughters—female carriers can develop phenotype later in life. 4

Critical Pitfalls to Avoid

  • Do not transfuse based solely on hemoglobin threshold—use the lowest dose to avoid transfusion needs, especially in CKD and cancer patients. 1, 6
  • Do not miss combined deficiencies—iron and B12 deficiency frequently coexist, particularly in elderly patients. 1
  • Do not overlook inflammation—ferritin can be falsely elevated in inflammatory states, masking iron deficiency. 4, 2
  • Do not delay workup in elderly patients—anemia always warrants investigation regardless of age. 1

References

Guideline

Diagnostic Approach and Management of Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Approach to Assessment of Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anemia: Evaluation and Diagnostic Tests.

The Medical clinics of North America, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

How to approach chronic anemia.

Hematology. American Society of Hematology. Education Program, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.